Title: Benmoxine
CAS Registry Number: 7654-03-7
CAS Name: Benzoic acid 2-(1-phenylethyl)hydrazide
Additional Names: 1-(benzoyl)-2-(a-methylbenzyl)hydrazine; 1-(a-methylbenzyl)-2-benzoylhydrazine
Trademarks: Neuralex (Millot)
Molecular Formula: C15H16N2O
Molecular Weight: 240.30
Percent Composition: C 74.97%, H 6.71%, N 11.66%, O 6.66%
Literature References: Prepn: Bettinetti, Farmaco Ed. Sci. 16, 823 (1961); FR 1314362 (1963 to I.C.I.), C.A. 59, 2716a (1963), corresp to GB 919491.
Properties: Crystals from isopropyl ether or petr ether + benzene, mp 93-94°.
Melting point: mp 93-94°
Therap-Cat: Antidepressant.
Keywords: Antidepressant; Hydrazides/Hydrazines.
Status: This monograph has been retired and is no longer subject to revision or update.
Benorylate Benoxacor Benoxaprofen Benoxinate Benperidol

Benmoxin skeletal.svg
Systematic (IUPAC) name
Clinical data
Legal status Prescription only
Routes Oral
CAS number 7654-03-7 N
ATC code None
PubChem CID 71671
ChemSpider 64728 YesY
Chemical data
Formula C15H16N2O 
Mol. mass 240.30 g/mol
 N (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]